pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Syndax Pharmaceuticals Inc ($SNDX) · catalysts · pharmadog
← back to Syndax Pharmaceuticals Inc
Catalysts for $SNDX
3
tracked
Nov 2, 2026
earnings
in 28d
Syndax Pharmaceuticals Inc earnings
Syndax Pharmaceuticals Inc
→
Oct 24, 2025
approval
12mo ago
REVUFORJ (REVUMENIB CITRATE) — FDA approval
revumenib citrate
→
Nov 15, 2024
approval
2y ago
REVUFORJ (REVUMENIB CITRATE) — FDA approval
revumenib citrate
→
$SNDX
17.60
-3.40%
$SNDX
17.60
-3.40%
$SNDX
17.60
-3.40%
